NDC 62795-1022 Bhi Cough
Antimony Potassium Tartrate, Atropa Belladonna, Blatta Orientalis, Bryonia Alba Whole, ...

Product Information

What is NDC 62795-1022?

The NDC code 62795-1022 is assigned by the FDA to the product Bhi Cough which is a human over the counter drug product labeled by Medinatura Inc. The generic name of Bhi Cough is antimony potassium tartrate, atropa belladonna, blatta orientalis, bryonia alba whole, anemone americana, star anise, ipecac, lobelia inflata, naphthalene, sodium sulfide nonahydrate, aspidosperma quebracho-blanco bark, and stachys officinalis. The product's dosage form is tablet and is administered via oral form. The product is distributed in a single package with assigned NDC code 62795-1022-3 1 bottle in 1 carton / 100 tablet in 1 bottle. This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information, RxNorm crosswalk and the complete product label.

NDC Product Code62795-1022
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Bhi Cough
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Antimony Potassium Tartrate, Atropa Belladonna, Blatta Orientalis, Bryonia Alba Whole, Anemone Americana, Star Anise, Ipecac, Lobelia Inflata, Naphthalene, Sodium Sulfide Nonahydrate, Aspidosperma Quebracho-blanco Bark, And Stachys Officinalis
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
Human Otc Drug
Dosage FormTablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route(s) What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.
  • Oral - Administration to or by way of the mouth.
Product Labeler Information What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.
Medinatura Inc
Labeler Code62795
Marketing Category What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
UNAPPROVED HOMEOPATHIC -
Start Marketing Date What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
08-30-2014
End Marketing Date What is the End Marketing Date?
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
03-31-2025
Exclude Flag What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".
N
NDC Code Structure

What are the uses for Bhi Cough?


Product Characteristics

Color(s)WHITE (C48325)
ShapeROUND (C48348)
Size(s)9 MM
Imprint(s)LEAFMAN
Score1

Product Packages

NDC Code 62795-1022-3

Package Description: 1 BOTTLE in 1 CARTON / 100 TABLET in 1 BOTTLE

Product Details

What are Bhi Cough Active Ingredients?

An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

Bhi Cough Active Ingredients UNII Codes

Bhi Cough Inactive Ingredients UNII Codes

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

Pharmacologic Class(es)

* Please review the disclaimer below.

Bhi Cough Product Label

FDA filings in the form of structured product labels are documents that include all published material associated whith this product. Product label information includes data like indications and usage generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Label Table of Contents



Questions?



Call weekdays 9am - 5pm EDT 1-844-MediNatura (1-844-633-4628) or email info @MediNatura.com


Active Ingredients



Each tablet contains: Antimonium tartaricum 6X, *Belladonna 6X, *Blatta orientalis 8X, *Bryonia alba 8X, *Hepatica triloba 5X, *Illicium anisatum 4X, *Ipecacuanha 4X, *Lobelia inflata 5X, Naphthalinum 6X, Natrum sulphuricum 6X, *Quebracho 6X, *Stachys betonica 4X 25 mg each.

*Natural Ingredients


Inactive Ingredients



Lactose, Magnesium stearate


Purpose



Cough Relief Tablets

Relieves Cough due to:

• Colds

• Throat Irritation

• Allergies


Uses



For the temporary relief of minor cough due to colds, throat irritation, and allergies.


Directions



At first sign of symptoms: Adults and children 4years and older:

1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. Do not exceed 12 tablets in 24 hours.

Standard dosage: Adults and children 4 years and older:

3 tablets per day, taking 1 tablet every 4 to 6 hours. For children under 4, consult your health professional.

Allow tablets to dissolve completely in the mouth, do not swallow

.


Warnings



If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. Ask a doctor if you have a cough that occurs with too much phlegm (mucus) or a cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema. Stop and ask a doctor if cough lasts for more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition. Do not use if known sensitivity to Cough or any of its ingredients exists.


Keep Out Of Reach Of Children



Keep out of reach of children


* Please review the disclaimer below.